To Be 17 Again - Anti-Interleukin-17 Treatment for Psoriasis

被引：44
|
作者：
Waisman, Ari [1 ]
机构：
[1] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 366卷 / 13期
关键词：
IL-17 CYTOKINE FAMILY; SKIN INFLAMMATION; HOST-DEFENSE; T-CELL; MICE; INTERLEUKIN-22; REQUIREMENT; DISEASES; IL-22;
D O I：
10.1056/NEJMe1201071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1251 / 1252
页数：2
相关论文
共 50 条
  • [31] AMG 827, an anti-interleukin-17 receptor antibody, improves psoriasis symptoms: Results from a randomized, controlled, phase II study
    Gordon, Kenneth B.
    Kimball, Alexa
    Chau, Dina
    Kricorian, Gregory
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (04) : AB184 - AB184
  • [32] Risankizumab effectiveness in a recalcitrant case of hidradenitis suppurativa after anti-TNF and anti-interleukin-17 failures
    Caposiena Caro, Raffaele Dante
    Pensa, Chiara
    Lambiase, Sara
    Candi, Eleonora
    Bianchi, Luca
    DERMATOLOGIC THERAPY, 2021, 34 (06)
  • [33] Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice
    Shen, Ning
    Wang, Jing
    Zhao, Mingwu
    Pei, Fei
    He, Bei
    INHALATION TOXICOLOGY, 2011, 23 (04) : 212 - 218
  • [34] Successful patch testing of a patient receiving anti-interleukin-17 therapy with secukinumab: a case report
    Hamann, Dathan
    Zirwas, Matthew
    CONTACT DERMATITIS, 2017, 76 (06) : 378 - 379
  • [35] Interleukin-17 Inhibitors work best in the Treatment of Psoriasis
    Di Lellis, Maddalena Angela
    AKTUELLE DERMATOLOGIE, 2020, 46 (04)
  • [36] Anti-Interleukin-17s for successful management of pustular psoriasis
    Guerra, Prisca
    Rosi, Elia
    Scandagli, Ilaria
    Silvi, Gianmarco
    Nunziati, Giulia
    Di Cesare, Antonella
    Prignano, Francesca
    CYTOKINE, 2023, 171
  • [37] Interleukin-17A and Keratinocytes in Psoriasis
    Furue, Masutaka
    Furue, Kazuhisa
    Tsuji, Gaku
    Nakahara, Takeshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [38] Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis
    Godse, Kiran
    INDIAN JOURNAL OF DERMATOLOGY, 2017, 62 (02) : 195 - 199
  • [39] Systematic review and meta-analysis: risk of new onset IBD with the use of anti-interleukin-17 agents
    Yamada, Akihiro
    Wang, Jingzhou
    Komaki, Yuga
    Komaki, Fukiko
    Micic, Dejan
    Sakuraba, Atsushi
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (04) : 373 - 385
  • [40] Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis
    Mease, Philip J.
    CURRENT OPINION IN RHEUMATOLOGY, 2015, 27 (02) : 127 - 133
12345